Company / Total Assets
BioAge Labs, Inc. Total Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$294.9M
FY2025
5-year range
$25.9M / $358.2M
FY2023-FY2025
Trend
-17.7%
vs FY2024
Sector context
#182 of 214
Health Care
What the data says
BioAge Labs, Inc.'s total assets of $295M is lower than 85% of companies in the Health Care sector (FY2025). Improved from $26M to $295M over the past 2 years.
Based on SEC 10-K filings.
$295M in FY2025.
Improved from $26M to $295M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 214This company $294.9M Sector average $7.5B
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, total assets decreased 17.7% year-over-year.
- Ranks #182 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $294.9M | -17.7% |
| FY2024 | $358.2M | +1281.9% |
| FY2023 | $25.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026